Evaluating the role of consolidative chest radiotherapy after chemo-immunotherapy in extensive-stage small cell lung cancer: a retrospective study
Our analysis shows that consolidative chest XRT is associated with improved overall survival in patients with ES-SCLC in patients receiving immunotherapy. These findings are hypothesis-generating and support ongoing randomized studies evaluating consolidative radiotherapy in the chemoimmunotherapy era.
Authors
- Mitchell Machtay (ORCID: https://orcid.org/0000-0002-0423-1231)
- Takefumi Komiya (ORCID: https://orcid.org/0000-0002-6484-2210)
- Joseph A. Miccio
- Junjia Zhu (ORCID: https://orcid.org/0000-0003-1311-3752)
- Natasha Venugopal
- Jorge Raul azquez-Urrutia
Institutions
- Pennsylvania State University (US)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1007/s12672-025-02589-x
- Citations
- 1
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Conquer Cancer Foundation
- American Society of Clinical Oncology